Pressure BioSciences (OTCQB: PBIO), a leader in the
development and sale of broadly enabling, pressure-based instruments,
consumables, and platform technology solutions to the worldwide biotechnology,
biotherapeutics and other industries, today announced the official opening of
its new Ultra Shear Technology(TM) (“UST”) Demonstration Laboratory. According
to the update, the major purpose of the UST Demo Lab, located in the company’s
South Easton, Massachusetts facility, is to showcase the ability of the company’s
revolutionary UST Platform to process CBD oil into true, high quality,
water-soluble nanoemulsions. A second purpose is to invite potential purchasers
of Pressure BioSciences’ UST-based BaroShear Systems (initial release expected
Q4 2020) to evaluate how their CBD and other product formulations work with the
company’s revolutionary UST platform. “The initial reactions from manufacturers
of topical and ingestible cannabidiol products processed in our lab during the
trial period have been extremely positive. They quickly saw how they could
realize substantial cost reductions while eliminating the overloading of poorly
water-soluble CBD and other cannabinoids into products to achieve targeted
dosing levels,” PBIO President and CEO Richard T. Schumacher said in the news
release. “We believe our breakthrough technology platform provides them with a
new-found ability to provide safe and effective dosing for their customers,
which in turn should stimulate greater growth in the market for CBD-based
products overall, and strong sales of our BaroShear product line when it is
released to the market later this year.”
To view the full press release, visit http://ibn.fm/6lLD6
About Pressure BioSciences Inc.
Pressure BioSciences is a leader in the development and sale
of innovative, broadly enabling, pressure-based solutions for the worldwide
life sciences industry. The company’s products are based on the unique
properties of both constant (i.e., static) and alternating (i.e., pressure
cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented, enabling
technology platform that uses alternating cycles of hydrostatic pressure
between ambient and ultra-high levels to safely and reproducibly control
bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s
primary focus is in the development of PCT-based products for biomarker and
target discovery, drug design and development, biotherapeutics characterization
and quality control, soil and plant biology, forensics and counter-bioterror
applications. Additionally, major new market opportunities have emerged in the
use of its pressure-based technologies in the following areas: (1) the use of
its recently acquired, patented technology from BaroFold Inc. (the “BaroFold”
technology) to allow entry into the biopharma contract services sector, and (2)
the use of its recently patented, scalable, high-efficiency, pressure-based
Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise
immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality,
homogenized, extended shelf-life or room-temperature, stable low-acid liquid
foods that cannot be effectively preserved using existing nonthermal
technologies. For more information, visit the company’s website at www.PressureBiosciences.com.
NOTE TO INVESTORS: The latest news and updates
relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment